John Sieckhaus - Nov 30, 2023 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Operating Officer
Signature
/s/ John Sieckhaus
Stock symbol
BSGM
Transactions as of
Nov 30, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/5/2023, 06:17 PM
Date Of Original Report
Dec 4, 2023
Previous filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Award $0 +92.3K +25.24% $0.00 458K Nov 30, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock.
F2 The shares of restricted stock fully vested on November 30, 2023, the date of the grant.